With regard to DN iNKT cells, they were shown to be skewed towards a Th1 phenotype in relapsing–remitting MS patients, who exhibited lower frequencies of IL-4 secreting DN iNKT cells [29]. This evidence concerns the gene IL4 and myeloid sarcoma.